Acoramidis Hydrochloride Global Patent Coverage & Expiry Overview

Track protection status across key markets to assess launch feasibility.

Start your free 7-Day Trial! Book a demo to explore our global patent data.

It is formulated by 1 pharmaceutical company such as BRIDGEBIO PHARMA. It is marketed under 1 brand name, including ATTRUBY. Available in 1 different strength, such as EQ 356MG BASE, and administered through 1 route including TABLET;ORAL.

Strategic Dashboard

info

insightsStrategic Insights

Sourcing & Feasibility

check_circle API availability: autorenew Loading API feasibility...

groups Licensing: 1 potential partners

calendar_todayUS Launch window: autorenew Loading launch window...

timeline Key Patent Barrier & Expiry Timeline

autorenew Loading patent barriers...

factoryGeneric Manufacturer Snapshot

autorenew Loading manufacturers...

gavelRisk & Opportunity Summary

dangerous Risk: autorenew Loading risk analysis...
watch_later Watch: autorenew Loading watch analysis...
rocket_launch Opportunity: autorenew Loading opportunity analysis...
flag
gavel
calendar_today
calendar_today

Access Global Patent Data

Stay ahead with worldwide patent expiry and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patents

Orange Book Drug Approval Timeline

FDA approval history for this ingredient

NDA (New Drug Application) ANDA (Generic Application)

Access Global Exclusivity and Patent Expiry Extensions

Stay ahead with worldwide patent expiry insights, exclusivity data, and latest updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
✓ Latest exclusivity data and extensions
Unlock Global Access

US Orange Book Patents Expiration Timeline

Key expiration dates for US patents covering this ingredient

View Global Patents Expiration Timeline

Stay ahead with worldwide patent expiry insights, market data, and research updates.

✓ Comprehensive global patent expiry timelines
✓ Full patent family details and status updates
Unlock Global Patent Timeline

Orange Book Drug Strengths

Latest drug strengths approved by FDA

Strength Route of Administration Companies Latest Approval Date

Orange Book Patents

Patents approved by the FDA for the ingredient

Patent Number Publication Date Legal Status Patent Expiry Date
{"application_id":"139425","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"d328ea48c2a143c980d3","publication_number":"US10398681B2","cleaned_patent_number":"10398681","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-05","publication_date":"2019-09-03","legal_status":"Granted"} US10398681B2 Formulation 03 Sep, 2019 Granted 05 May, 2031
{"application_id":"139421","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"d328ea48c2a143c980d3","publication_number":"US10842777B2","cleaned_patent_number":"10842777","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-05","publication_date":"2020-11-24","legal_status":"Granted"} US10842777B2 24 Nov, 2020 Granted 05 May, 2031
{"application_id":"139427","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"","publication_number":"US8877795B2","cleaned_patent_number":"8877795","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-05","publication_date":"2014-11-04","legal_status":"Granted"} US8877795B2 Formulation 04 Nov, 2014 Granted 05 May, 2031
{"application_id":"139418","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"d328ea48c2a143c980d3","publication_number":"US9169214B2","cleaned_patent_number":"9169214","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-05","publication_date":"2015-10-27","legal_status":"Granted"} US9169214B2 Formulation 27 Oct, 2015 Granted 05 May, 2031
{"application_id":"139426","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"d328ea48c2a143c980d3","publication_number":"US9642838B2","cleaned_patent_number":"9642838","drug_product_flag":"Y","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-05","publication_date":"2017-05-09","legal_status":"Patented case"} US9642838B2 Molecular Formulation 09 May, 2017 Patented case 05 May, 2031
{"application_id":"139419","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"d328ea48c2a143c980d3","publication_number":"US9913826B2","cleaned_patent_number":"9913826","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2031-05-05","publication_date":"2018-03-13","legal_status":"Patented case"} US9913826B2 13 Mar, 2018 Patented case 05 May, 2031
{"application_id":"139428","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"11a933281e034a328aba","publication_number":"US10513497B2","cleaned_patent_number":"10513497","drug_product_flag":"-","drug_substance_flag":"Y","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-16","publication_date":"2019-12-24","legal_status":"Granted"} US10513497B2 Molecular 24 Dec, 2019 Granted 16 Feb, 2038
{"application_id":"139422","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"11a933281e034a328aba","publication_number":"US11919865B2","cleaned_patent_number":"11919865","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2038-02-16","publication_date":"2024-03-05","legal_status":"Granted"} US11919865B2 05 Mar, 2024 Granted 16 Feb, 2038
{"application_id":"139423","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"","publication_number":"US12070449B2","cleaned_patent_number":"12070449","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-03-22","publication_date":"2024-08-27","legal_status":"Granted"} US12070449B2 27 Aug, 2024 Granted 22 Mar, 2039
{"application_id":"139420","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"","publication_number":"US11058668B2","cleaned_patent_number":"11058668","drug_product_flag":"-","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-03-22","publication_date":"2021-07-13","legal_status":"Granted"} US11058668B2 13 Jul, 2021 Granted 22 Mar, 2039
{"application_id":"139424","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"","publication_number":"US12005043B2","cleaned_patent_number":"12005043","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-08-16","publication_date":"2024-06-11","legal_status":"Granted"} US12005043B2 Formulation 11 Jun, 2024 Granted 16 Aug, 2039
{"application_id":"139429","ingredient":"ACORAMIDIS HYDROCHLORIDE","trade_name":"ATTRUBY","family_id":"","publication_number":"US11260047B2","cleaned_patent_number":"11260047","drug_product_flag":"Y","drug_substance_flag":"-","use_codes":["-"],"definitions":["-"],"patent_expire_date_text":"2039-08-16","publication_date":"2022-03-01","legal_status":"Patented Case"} US11260047B2 Formulation 01 Mar, 2022 Patented Case 16 Aug, 2039

Recent Clinical Trials

Latest clinical trials and research studies for this ingredient

NCT ID Title Status Phase Conditions Start Date Completion Date

API Suppliers/Manufacturer (Branded/Generic companies)

Manufacturing Locations

View Complete Supplier List

Unlock access to all suppliers of Acoramidis Hydrochloride

✓ Access a comprehensive list of global suppliers
✓ Get information on each supplier
Unlock Suppliers

Note: Patent expirations and exclusivity timelines are dynamic and may shift based on litigation, regulatory extensions, and maintenance filings. Regular monitoring is advised.

GreyB © 2025 Elixir. All rights reserved.